Document Type

Article

Publication Date

Spring 4-27-2025

Abstract

This research focuses on the development, design, implementation, and testing (with complete hardware and software integration) of a 6D Electromagnetic Actuation (EMA) system for the precise control and navigation of micro/nanorobots (MNRs) in high-viscosity fluids, addressing critical challenges in targeted drug delivery within complex biological environments, such as blood vessels. The primary objective is to overcome limitations in the actuation efficiency, trajectory stability, and accurate path-tracking of MNRs. The EMA system utilizes three controllable orthogonal pairs of Helmholtz coils to generate uniform magnetic fields, which magnetize and steer MNRs in 3D for orientation. Another three controllable orthogonal pairs of Helmholtz coils generate uniform magnetic fields for the precise 3D orientation and steering of MNRs. Additionally, three orthogonal pairs of Maxwell coils generate uniform magnetic field gradients, enabling efficient propulsion in dynamic 3D fluidic environments in real time. This hardware configuration is complemented by three high-resolution digital microscopes that provide real-time visual feedback, enable the dynamic tracking of MNRs, and facilitate an effective closed-loop control mechanism. The implemented closed-loop control technique aimed to enhance trajectory accuracy, minimize deviations, and ensure the stable movement of MNRs along predefined paths. The system’s functionality, operation, and performance were tested and verified through various experiments, focusing on hardware, software integration, and the control algorithm. The experimental results show the developed system’s ability to activate MNRs of different sizes (1 mm and 0.5 mm) along selected desired trajectories. Additionally, the EMA system can stably position the MNR at any point within the 3D fluidic environment, effectively counteracting gravitational forces while adhering to established safety standards for electromagnetic exposure to ensure biocompatibility and regulatory compliance.

Download

Share

COinS